c-myc overexpression uncouples DNA replication from mitosis

Molecular and Cellular Biology

Volumn 19, Issue 8, 1999, Pages 5339-5351

  Li, Qing ^a   Dang, Chi V ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DEMECOLCINE; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER; CANCER GROWTH; CELL CYCLE G1 PHASE; CHROMOSOME SEGREGATION; DNA REPLICATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MITOSIS; NONHUMAN; ONCOGENE C MYC; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALIA; MURINAE; RODENTIA;

EID: 0032814141     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.8.5339     Document Type: Article

References (66)

1. Alevizopoulos, K., J. Vlach, S. Hennecke, and B. Amati. 1997. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J. 16:5322-5333.
2. Amati, B., K. Alevizopoulos, and J. Vlach. 1998. Myc and the cell cycle. Front. Biosci. 3:250-268.
3. cdc2 inactivation and mitotic exit in mammalian cells. J. Cell Biol. 127: 789-802.
4. Barr, L. F., S. E. Campbell, M. B. Penno, D. W. Ball, and S. B. Baylin. 1996. Cell-substratum interactions mediate oncogene-induced phenotype of lung cancer cells. Cell Growth Differ. 7:1149-1156.
5. 1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene 15:1347-1356.
6. Bignon, Y. J., J. Y. Shew, D. Rappolee, S. L. Naylor, E. Y. Lee, J. Schnier, and W. H. Lee. 1990. A single Cys706 to Phe substitution in the retinoblastoma protein causes the loss of binding to SV40 T antigen. Cell Growth Differ. 1:647-651.
7. Botz, J., K. Zerfass-Thome, D. Spitkovsky, H. Delius, B. Vogt, M. Eilers, A. Hatzigeorgiou, and P. Jansen-Durr. 1996. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16:3401-3409.
8. Cahill, D. P., C. Lengauer, J. Yu, G. J. Riggins, J. K. Wilson, S. D. Markowitz, K. W. Kinzler, and B. Vogelstein. 1998. Mutations of mitotic checkpoint genes in human cancers. Nature 392:300-303.
9. 1 cell cycle checkpoint pathway and ataxiatelangiectasia. Cancer Res. 54:5054-5058.
10. 1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16:2445-2452.
11. Chen, R. H., J. C. Waters, E. D. Salmon, and A. W. Murray. 1996. Association of spindle assembly checkpoint component XMAD2 with unattached kinetochores. Science 274:242-246.
12. Cross, S. M., C. A. Sanchez, C. A. Morgan, M. K. Schimke, S. Ramel, R. L. Idzerda, W. H. Raskind, and B. J. Reid. 1995. A p53-dependent mouse spindle checkpoint. Science 267:1353-1356.
13. Davis, F. M., T. Y. Tsao, S. K. Fowler, and P. N. Rao. 1983. Monoclonal antibodies to mitotic cells. Proc. Natl. Acad. Sci. USA 80:2926-2930.
14. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
15. Dickson, R. Personal communication.
16. Di Leonardo, A., S. H. Khan, S. P. Linke, V. Greco, G. Seidita, and G. M. Wahl. 1997. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57:1013-1019.
17. Dulic, V., E. Lees, and S. I. Reed. 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958-1961.
18. Duronio, R. J., A. Brook, N. Dyson, and P. H. O'Farrell. 1996. E2F-induced S phase requires cyclin E. Genes Dev. 10:2505-2513.
19. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
20. Elledge, S. J. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1672.
21. Facchini, L. M., and L. Z. Penn. 1998. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12: 633-651.
22. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517.
23. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
24. Gorczyca, W., J. Gong, and Z. Darzynkiewicz. 1993. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1945-1951.
25. Grandori, C., and R. N. Eisenman. 1997. Myc target genes. Trends Biochem. Sci. 22:177-181.
26. Hartwell, L. H., and M. B. Kastan. 1994. Cell cycle control and cancer. Science 266:1821-1828.
27. Hoang, A. T., B. Lutterbach, B. C. Lewis, T. Yano, T.-Y. Chou, J. F. Barrett, M. Raffeld, S. R. Hann, and C. V. Dang. 1995. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell. Biol. 15:4031-4042.
28. Hoyt, M. A., L. Totis, and B. T. Roberts. 1991. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66:507-517.
29. 1 arrest. Cancer Res. 58:396-401.
30. Knoblich, J. A., K. Sauer, L. Jones, R. Richardson, R. Saint, and C. F. Lehner. 1994. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell 77:107-120.
31. 1 phase of the human cell cycle. Science 257:1689-1694.
32. Kung, A. L., S. W. Sherwood, and R. T. Schimke. 1990. Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc. Natl. Acad. Sci. USA 87:9553-9557.
33. Lanni, J. S., and T. Jacks. 1998. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18: 1055-1064.
34. Lee, L., and C. V. Dang. Unpublished data.
35. 1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Curr. Biol. 7:709-712.
36. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
37. Li, R., and A. W. Murray. 1991. Feedback control of mitosis in budding yeast. Cell 66:519-531.
38. Li, Y., and R. Benezra. 1996. Identification of a human mitotic checkpoint gene: hsMAD2. Science 274:246-248.
39. Lukas, J., T. Herzinger, K. Hansen, M. C. Moroni, D. Resnitzky, K. Helin, S. I. Reed, and J. Bartek. 1997. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11:1479-1492.
40. Mai, S., J. Hanky-Hyde, and M. Fluri. 1996. c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines. Oncogene 12:277-288.
41. McMahon, S. B., H. A. Van Buskirk, K. A. Dugan, T. D. Copeland, and M. D. Cole. 1998. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94:363-374.
42. Minn, A. J., L. H. Boise, and C. B. Thompson. 1996. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev. 10:2621-2631.
43. Nasmyth, K. 1996. Viewpoint: putting the cell cycle in order. Science 274: 1643-1645.
44. Nurse, P. 1994. Ordering S phase and M phase in the cell cycle. Cell 79:547-550.
45. Ohtani, K., J. DeGregori, and J. R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92:12146-12150.
46. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
47. Packham, G., and J. L. Cleveland. 1995. c-Myc and apoptosis. Biochim. Biophys. Acta 1242:11-28.
48. Pangilinan, F., Q. Li, T. Weaver, B. C. Lewis, C. V. Dang, and F. Spencer. 1997. Mammalian BUB1 protein kinases: map positions and in vivo expression. Genomics 46:379-388.
49. Paulovich, A. G., D. P. Toczjski, and L. H. Hartwell. 1997. When checkpoints fail. Cell 88:315-321.
50. Perez-Roger, I., D. L. Solomon, A. Sewing, and H. Land. 1997. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 14: 2373-2381.
51. Qin, X. Q., D. M. Livingston, W. G. Kaelin, Jr., and P. D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918-10922.
52. 1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
53. Ricketts, M. H., and A. D. Levinson. 1988. High-level expression of c-H-ras1 fails to fully transform Rat-1 cells. Mol. Cell. Biol. 8:1460-1468.
54. Roberts, J. M., A. Koff, K. Polyak, E. Firpo, S. Collins, M. Ohtsubo, and J. Massague. 1994. Cyclins, Cdks, and cyclin kinase inhibitors. Cold Spring Harbor Symp. Quant. Biol. 59:31-38.
55. Sargent, L. M., N. D. Sanderson, and S. S. Thorgeirsson. 1996. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes. Cancer Res. 56:2137-2142.
56. Shim, H., Y. S. Chun, B. C. Lewis, and C. V. Dang. 1998. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. USA 95:1511-1516.
57. Small, M. B., N. Hay, M. Schwab, and J. M. Bishop. 1987. Neoplastic transformation by the human gene n-myc. Mol. Cell. Biol. 7:1638-1645.
58. 1 cyclin-cdk complexes. EMBO J. 14:4814-4826.
59. Taylor, S. S., E. Ha, and F. McKeon. 1998. The human homologue of bub3 is required for kinetochore localization of bub1 and a Mad3/Bub1-related protein kinase. J. Cell Biol. 142:1-11.
60. Taylor, S. S., and F. McKeon. 1997. Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89:727-735.
61. Thompson, E. W., J. Torri, M. Sabol, C. L. Sommers, S. Byers, E. M. Valverius, G. R. Martin, M. E. Lippman, M. R. Stampfer, and R. B. Dickson. 1994. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin. Exp. Metastasis 12:181-194.
62. Vlach, J., S. Hennecke, K. Alevizopoulos, D. Conti, and B. Amati. 1996. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 15:6595-6604.
63. Weinberg, R. A. 1996. E2F and cell proliferation: a world turned upside down. Cell 85:457-459.
64. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
65. Yin, X. Y., L. Grove, N. S. Datta, M. W. Long, and E. V. Prochownik. 1999 C-myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene 18:1177-1184.
66. Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12: 2424-2433.